DIVISLAB fundamentals
DIVI S LABORATORIES LTD revenue breakdown overview
DIVI S LABORATORIES LTD revenue for the last year amounted to 93.60 B INR, the most of which — 78.45 B INR — came from its highest performing source at the moment, Active Pharmaceutical Ingredients and Intermediates, the year earlier bringing 77.68 B INR. The greatest contribution to the revenue figure was made by Europe — last year it brought DIVI S LABORATORIES LTD 30.36 B INR, and the year before that — 31.87 B INR.
By source
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
0.00
25.00 B
50.00 B
75.00 B
100.00 B
Active Pharmaceutical Ingredients and Intermediates
Currency: INR
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Active Pharmaceutical Ingredients and Intermediates
53.94 B
69.69 B
89.60 B
77.68 B
78.45 B
By country
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
0.00
25.00 B
50.00 B
75.00 B
100.00 B
Europe
United States
Switzerland
Asia
India
Americas
Rest of the World
North America
Currency: INR
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Europe
25.52 B
32.31 B
28.80 B
31.87 B
30.36 B
United States
9.93 B
13.79 B
20.05 B
18.47 B
10.47 B
Switzerland
—
—
—
—
10.25 B
Asia
5.95 B
8.27 B
7.98 B
10.41 B
10.17 B
India
7.84 B
9.12 B
10.38 B
9.76 B
9.84 B
Americas
2.56 B
3.21 B
18.93 B
3.68 B
3.85 B
Rest of the World
2.15 B
2.99 B
3.46 B
3.49 B
3.51 B
North America
—
—
—
—
—